AVVYY yields 3.30% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, AVVYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVVYY + JNJ for your $10,000?
AVEVA Group plc, through its subsidiaries, provides engineering and industrial software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers engineering, procurement, and construction; asset performance management; monitoring and control; planning and scheduling; and operation and optimization industrial software solutions. It also provides digital transformation solutions covering artificial intelligence, cloud, digital twin, edge, extended reality, and Industrial Internet of Things products; and customer support and training services. The company serves customers in the chemicals, food and beverage, consumer packaged goods, infrastructure, life sciences, marine, mining, oil and gas, power and utilities, pulp and paper, steel fabrication, and water and wastewater industries. The company was founded in 1967 and is based in Cambridge, the United Kingdom. AVEVA Group plc is a subsidiary of Schneider Electric SE.
Full AVVYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.